William S. Marth

Biography

A director of the company since 2012, William Marth has served as president and chief executive officer of AMRI since 2014. He also served as chairman of the board in 2013. Prior to joining AMRI, Mr. Marth served as president and CEO of Teva Pharmaceutical Industries Ltd. in the Americas as well as CEO of Teva North America and Teva USA. In addition, he worked with several large equity firms providing guidance on their health care investments. He was a member of Teva’s global executive management team from 2007 to 2012 and before that was executive vice president and vice president of sales and marketing for Teva USA. Prior to joining Teva USA, he held various positions with the Apothecon division of Bristol-Myers Squibb. Mr. Marth earned a bachelor’s in pharmacy from the University of Illinois and his MBA from the Keller Graduate School of Management, DeVry University and an honorary D.H.L. from the Albany College of Pharmacy and Health Sciences. He is a pharmacist and is currently a director at Galmed and the University of Illinois at Chicago College of Pharmacy. Previously, Mr. Marth served as the chairman of the board of the Generic Pharmaceutical Association and the American Society for Health-System Pharmacists, as well as on various boards and committees, including the University of the Sciences in Philadelphia and the board of ambassadors for Johns Hopkins Project RESTORE. 

Research Interest

 Pharmacology